The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients

被引：0
作者：
Ueda, M [1 ]
Hirokane, G [1 ]
Morita, S [1 ]
Yokono, A [1 ]
Okawa, M [1 ]
Shimoda, K [1 ]
机构：
[1] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S223 / S223
页数：1
相关论文
共 50 条
[31]   Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia [J].
Kosuke Doki ;
Masato Homma ;
Keisuke Kuga ;
Kazutomi Kusano ;
Shigeyuki Watanabe ;
Iwao Yamaguchi ;
Yukinao Kohda .
European Journal of Clinical Pharmacology, 2006, 62 :919-926
[32]   Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia [J].
Kosuke Doki ;
Masato Homma ;
Keisuke Kuga ;
Kazutomi Kusano ;
Shigeyuki Watanabe ;
Iwao Yamaguchi ;
Yukinao Kohda .
European Journal of Clinical Pharmacology, 2007, 63 :217-218
[33]   Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients [J].
Berecz, R ;
Llerena, A ;
de la Rubia, A ;
Gómez, J ;
Kellermann, M ;
Dorado, P ;
Degrell, I .
PHARMACOPSYCHIATRY, 2002, 35 (06) :231-234
[34]   Using CYP2D6 genotype to understand paroxetine-pimozide pharmacokinetics in man [J].
Foot, Elizabeth ;
Briley, Linda ;
McCarthy, Linda ;
Moate, Rachel ;
Reck, Brian ;
Muir, Keith ;
Stapleton, Carole ;
Cox, Charles ;
Dow, David ;
Mehta, Nalini ;
Latham, Ian ;
Goodgame, Neil ;
Vousden, Marika ;
Nucci, Gianluca .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) :786-786
[35]   Pharmacokinetics of atomoxetine after administration of paroxetine in relation to CYP2D6 genotype status [J].
Kim, Dong-Hyun ;
Lim, Hye-Jin ;
Byeon, Ji-Yeong ;
Kim, Young-Hoon ;
Kim, Se-Hyung .
PHARMACOTHERAPY, 2015, 35 (11) :E316-E317
[36]   Effect of the CYP2D6 genotype on prolactin concentration in schizophrenic patients treated with haloperidol [J].
Yasui-Furukori, N ;
Kondo, T ;
Suzuki, A ;
Mihara, K ;
Tokinaga, N ;
Inoue, Y ;
Otani, K ;
Kaneko, S .
SCHIZOPHRENIA RESEARCH, 2001, 52 (1-2) :139-142
[37]   Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression [J].
Komahashi-Sasaki, Hazuki ;
Yasui-Furukori, Norio ;
Sasaki, Taro ;
Shinozaki, Masataka ;
Hayashi, Yuki ;
Kato, Kazuko ;
Inoue, Yoshimasa ;
Tsuchimine, Shoko ;
Watanabe, Takashi ;
Sugawara, Norio ;
Shimoda, Kazutaka .
THERAPEUTIC DRUG MONITORING, 2021, 43 (05) :681-687
[38]   Effect of CYP2D6*10 polymorphism on mirtazapine metabolism in Japanese psychiatric patients [J].
Watanabe, T. ;
Hyashi, Y. ;
Aoki, A. ;
Ishiguro, S. ;
Inoue, Y. ;
Akiyama, K. ;
Tsuchimine, S. ;
Yasui-Furukori, N. ;
Shimoda, K. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 :S462-S463
[39]   Relationship of venlafaxine, fluoxetine, sertraline, and paroxetine plasma concentration with CYP 2D6 inhibition [J].
Alfaro, C ;
Ereshefsky, L ;
Lam, YWF .
PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) :488-488
[40]   The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients [J].
Mihara, K ;
Otani, K ;
Tybring, G ;
Dahl, ML ;
Bertilsson, L ;
Kaneko, S .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (06) :467-471
12345